Mitsubishi UFJ Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,605
| Closed | -$98.9K | – | 1627 |
|
|
2025
Q1 | $98.9K | Buy |
30,605
+2,564
| +9% | +$8.28K | ﹤0.01% | 1027 |
|
|
2024
Q4 | $166K | Buy |
28,041
+17,576
| +168% | +$104K | ﹤0.01% | 1017 |
|
|
2024
Q3 | $113K | Sell |
10,465
-983
| -9% | -$10.6K | ﹤0.01% | 1018 |
|
|
2024
Q2 | $240K | Sell |
11,448
-7,519
| -40% | -$158K | ﹤0.01% | 943 |
|
|
2024
Q1 | $604K | Sell |
18,967
-868
| -4% | -$27.7K | ﹤0.01% | 852 |
|
|
2023
Q4 | $400K | Buy |
19,835
+4,557
| +30% | +$91.9K | ﹤0.01% | 945 |
|
|
2023
Q3 | $194K | Buy |
15,278
+820
| +6% | +$10.4K | ﹤0.01% | 1025 |
|
|
2023
Q2 | $261K | Buy |
14,458
+2,422
| +20% | +$43.8K | ﹤0.01% | 1004 |
|
|
2023
Q1 | $207K | Hold |
12,036
| – | – | ﹤0.01% | 1024 |
|
|
2022
Q4 | $248K | Buy |
+12,036
| New | +$248K | ﹤0.01% | 1001 |
|
|
2022
Q2 | – | Sell |
-13,443
| Closed | -$203K | – | 1164 |
|
|
2022
Q1 | $203K | Buy |
13,443
+905
| +7% | +$13.7K | ﹤0.01% | 1054 |
|
|
2021
Q4 | $284K | Buy |
+12,538
| New | +$284K | ﹤0.01% | 1021 |
|